Pharma

ProImmune and Roslin Institute Partner to Expand Tools for Veterinary Immunology

Collaboration aims to develop species-specific binders to accelerate research and improve control of zoonotic diseases.

Inside Nxera Pharma’s Next-Generation Biopharma Model

From AI-enabled GPCR discovery to partnership-driven growth, Nxera is redefining how medicines are built and commercialised.

Belite Bio Announces Landmark Phase 3 Success for Stargardt Disease

Tinlarebant becomes the first therapy to show clinical benefit in a pivotal global trial, reducing retinal lesion growth by 36% and paving the way for a planned FDA filing in 2026.

Study Shows TREMFYA® Slows Psoriatic Arthritis Progression at 48 Weeks

Long-term APEX results reinforce TREMFYA® as the only IL-23 inhibitor proven to slow structural joint damage in psoriatic arthritis.

World-First Preventative Lung Cancer Vaccine Enters Clinical Trial

A groundbreaking clinical trial set to begin in summer 2026 will test LungVax, the world’s first vaccine designed to prevent lung cancer in people at high risk, a major milestone in cancer prevention research.

Optibrium Launches StarDrop 8, Bringing Real-Time Collaboration to Molecular Design

StarDrop 8 integrates real-time collaboration into compound design and optimisation, streamlining decision-making and improving team productivity.